Compare HMR & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HMR | XTNT |
|---|---|---|
| Founded | 1984 | N/A |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.1M | 82.6M |
| IPO Year | N/A | N/A |
| Metric | HMR | XTNT |
|---|---|---|
| Price | $0.76 | $0.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.00 | $1.50 |
| AVG Volume (30 Days) | 54.8K | ★ 241.1K |
| Earning Date | 02-11-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $36,086,264.00 | ★ $133,083,000.00 |
| Revenue This Year | $52.26 | $15.08 |
| Revenue Next Year | $45.18 | N/A |
| P/E Ratio | ★ N/A | $69.41 |
| Revenue Growth | 7.41 | ★ 16.88 |
| 52 Week Low | $0.80 | $0.34 |
| 52 Week High | $10.04 | $0.95 |
| Indicator | HMR | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 19.77 | 58.53 |
| Support Level | $0.80 | $0.75 |
| Resistance Level | $1.23 | $0.83 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 3.13 | 62.44 |
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.